Hepatology

Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.

A 2023 global call to action by over 300 experts highlighted the need for clear, cross-specialty care pathways to support earlier identification and referral of people at risk.

Bacterial peritonitis can either arise spontaneously or occur secondary to abscesses or perforations in the abdominal cavity. Both…

In this double-blind, placebo-controlled trial, 181 participants were randomised to receive weekly injections of either 28 mg or 50 mg of efruxifermin or a placebo.

These figures indicate a substantial drop-off following diagnosis, undermining efforts to eliminate HCV in paediatric populations.

What we set out to do, and what we’ve continued working on, is exploring all the ways we could create the best possible Congress…

It always takes a village to organise an event the size of the EASL Congress. We had close to 8,000 registrants, so it was a huge…

The model analyses demographic information, lab results, and other clinical data to predict the cause of graft injury across six possible conditions.